ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Recruiting

• Conditions: Non-Hodgkin's Lymphoma; Mycosis Fungoides

• Registration Number: NCT02848274
• Lead Sponsor: Stanford University

Brief Summary

The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2016-07-25
• Study First Submitted QC: 2016-07-25
• Study First Posted: 2016-07-28
• Study Start: 2016-10
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-01
• Last Update Posted: 2024-10-02
• Primary Completion: 2027-03
• Study Completion: 2027-03

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival (OS)	date of diagnosis to death from any cause, up to two years

Trial Locations

Locations (13)

City of Hope; 🇺🇸 Duarte, California, United States

Stanford University, School of Medicine; 🇺🇸 Palo Alto, California, United States

University of Iowa; 🇺🇸 Iowa City, Iowa, United States

Hackensack University Medical Center; 🇺🇸 Hackensack, New Jersey, United States

University of Pittsburg; 🇺🇸 Pittsburgh, Pennsylvania, United States

University of Texas Southwestern; 🇺🇸 Dallas, Texas, United States

University of Utah Hospital; 🇺🇸 Salt Lake City, Utah, United States

Hospital Italiano de Buenos Aires; 🇦🇷 Buenos Aires, Argentina

Peter MacCallum Cancer Center,; 🇦🇺 Melbourne, Australia

University of Sao Paulo Medical School; 🇧🇷 Sao Paulo, Brazil

Scroll for more (3 remaining)